Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AHCO NASDAQ:AMED NYSE:CHE NASDAQ:OPCH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAHCOAdaptHealth$10.45-0.8%$11.59$8.06▼$13.43$1.42B1.571.57 million shs730,698 shsAMEDAmedisys$101.01+0.0%$99.72$92.44▼$101.02$3.32B0.89509,062 shs1.06 million shsCHEChemed$439.70-0.4%$400.27$365.20▼$581.20$5.83B0.54265,709 shs162,103 shsOPCHOption Care Health$20.93-2.7%$25.96$18.01▼$36.80$3.29B0.685.23 million shs2.48 million shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAHCOAdaptHealth0.00%-1.97%-17.91%+1.06%+15.34%AMEDAmedisys0.00%0.00%0.00%0.00%+7.93%CHEChemed0.00%+1.21%+14.68%-7.50%-23.04%OPCHOption Care Health0.00%+7.22%-26.66%-41.36%-36.01%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAHCOAdaptHealth$10.45-0.8%$11.59$8.06▼$13.43$1.42B1.571.57 million shs730,698 shsAMEDAmedisys$101.01+0.0%$99.72$92.44▼$101.02$3.32B0.89509,062 shs1.06 million shsCHEChemed$439.70-0.4%$400.27$365.20▼$581.20$5.83B0.54265,709 shs162,103 shsOPCHOption Care Health$20.93-2.7%$25.96$18.01▼$36.80$3.29B0.685.23 million shs2.48 million shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAHCOAdaptHealth0.00%-1.97%-17.91%+1.06%+15.34%AMEDAmedisys0.00%0.00%0.00%0.00%+7.93%CHEChemed0.00%+1.21%+14.68%-7.50%-23.04%OPCHOption Care Health0.00%+7.22%-26.66%-41.36%-36.01%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAHCOAdaptHealth 2.50Moderate Buy$14.2936.71% UpsideAMEDAmedisys 0.00N/AN/AN/ACHEChemed 2.33Hold$501.5014.05% UpsideOPCHOption Care Health 2.69Moderate Buy$31.2549.31% UpsideCurrent Analyst Ratings BreakdownLatest CHE, AMED, OPCH, and AHCO Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/11/2026OPCHOption Care Health Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold (C) ➝ Hold (C-)5/11/2026AHCOAdaptHealth Royal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$13.00 ➝ $15.005/11/2026OPCHOption Care Health Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell5/6/2026OPCHOption Care Health Morgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$28.005/6/2026AHCOAdaptHealth Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$14.00 ➝ $16.005/6/2026AHCOAdaptHealth Robert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$18.005/6/2026AHCOAdaptHealth UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$15.00 ➝ $14.005/6/2026OPCHOption Care Health Morgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight5/4/2026OPCHOption Care Health JPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOverweight$40.00 ➝ $33.005/1/2026OPCHOption Care Health Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$30.005/1/2026OPCHOption Care Health Barrington ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOutperform$42.00 ➝ $32.00(Data available from 5/24/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAHCOAdaptHealth$3.24B0.44$4.18 per share2.50$11.14 per share0.94AMEDAmedisys$2.40B1.38$6.24 per share16.20$38.77 per share2.61CHEChemed$2.53B2.31$24.69 per share17.81$63.88 per share6.88OPCHOption Care Health$5.65B0.58$2.04 per share10.24$8.60 per share2.43Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAHCOAdaptHealth-$70.79M-$0.62N/A10.660.59-2.42%2.76%0.99%8/4/2026 (Estimated)AMEDAmedisys$43.23M$2.5739.3020.871.343.56%12.91%7.29%N/ACHEChemed$265.24M$18.3523.9617.261.6510.23%27.18%17.38%8/4/2026 (Estimated)OPCHOption Care Health$207.59M$1.2916.2211.381.163.64%18.17%7.16%7/29/2026 (Estimated)Latest CHE, AMED, OPCH, and AHCO EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/5/2026Q1 2026AHCOAdaptHealth$0.0125-$0.12-$0.1325-$0.12$796.63 million$819.80 million4/30/2026Q1 2026OPCHOption Care Health$0.37$0.40+$0.03$0.29$1.39 billion$1.35 billion4/23/2026Q1 2026CHEChemed$5.30$5.65+$0.35$4.84$659.22 million$657.51 million2/25/2026Q4 2025CHEChemed$7.02$6.42-$0.60$5.48$659.09 million$639.34 million2/24/2026Q4 2025AHCOAdaptHealth$0.34-$0.76-$1.10-$0.76$832.51 million$846.29 million2/24/2026Q4 2025OPCHOption Care Health$0.46$0.46N/A$0.37$1.46 billion$1.47 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthAHCOAdaptHealthN/AN/AN/AN/AN/AAMEDAmedisysN/AN/AN/AN/AN/ACHEChemed$2.400.55%+10.76%13.08%16 YearsOPCHOption Care HealthN/AN/AN/AN/AN/ALatest CHE, AMED, OPCH, and AHCO DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/18/2026CHEChemedquarterly$0.600.54%5/28/20265/28/20266/16/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAHCOAdaptHealth1.210.920.71AMEDAmedisys0.261.361.36CHEChemed0.110.850.83OPCHOption Care Health0.851.641.07Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAHCOAdaptHealth82.67%AMEDAmedisys94.36%CHEChemed95.85%OPCHOption Care Health98.05%Insider OwnershipCompanyInsider OwnershipAHCOAdaptHealth1.95%AMEDAmedisys2.10%CHEChemed3.33%OPCHOption Care Health1.70%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAHCOAdaptHealth10,900135.91 million133.27 millionOptionableAMEDAmedisys20,00032.89 million32.20 millionOptionableCHEChemed15,81113.27 million12.83 millionOptionableOPCHOption Care Health8,266157.03 million154.36 millionOptionableCHE, AMED, OPCH, and AHCO HeadlinesRecent News About These CompaniesOption Care Health Shareholders Back Board, Pay, AuditorMay 22 at 5:31 PM | tipranks.comSecurities Fraud Investigation Into Option Care Health, Inc. (OPCH) Continues - Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading ...May 21 at 11:35 PM | tmcnet.comOPCH INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Option Care Health, Inc.May 21 at 8:00 PM | globenewswire.comOption Care (OPCH) Climbs 5.9% on US Healthcare DevelopmentsMay 20, 2026 | finance.yahoo.comSecurities Fraud Investigation Into Option Care Health, Inc. (OPCH) Continues - Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. CruzMay 20, 2026 | tmcnet.comSecurities Fraud Investigation Into Option Care Health, Inc. (OPCH) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law FirmMay 20, 2026 | businesswire.comOption Care Health, Inc. (OPCH) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud InvestigationMay 20, 2026 | businesswire.comSecurities Fraud Investigation Into Option Care Health, Inc. (OPCH) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. CruzMay 20, 2026 | businesswire.comOption Care Health (OPCH) Securities Fraud Investigation - Levi & KorsinskyMay 20, 2026 | prnewswire.comOPCH INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Option Care Health, Inc.May 19, 2026 | businesswire.comOption Care Health (NASDAQ:OPCH) Trading 5.6% Higher - Should You Buy?May 19, 2026 | marketbeat.comGamco Investors INC. ET AL Boosts Stock Position in Option Care Health, Inc. $OPCHMay 19, 2026 | marketbeat.comOption Care Health Investors Should Contact Block & Leviton to Possibly Recover LossesMay 18, 2026 | newsfilecorp.comNStaley Capital Advisers Inc. Sells 75,000 Shares of Option Care Health, Inc. $OPCHMay 17, 2026 | marketbeat.comRosen Law Firm Encourages Option Care Health, Inc. Investors to Inquire About Securities Class Action Investigation - OPCHMay 16, 2026 | tmcnet.comOption Care Health (OPCH) price target decreased by 28.18% to 29.38May 16, 2026 | msn.comRosen Law Firm Encourages Option Care Health, Inc. Investors to Inquire About Securities Class Action Investigation – OPCHMay 15, 2026 | businesswire.comLeeward Investments LLC MA Purchases 64,868 Shares of Option Care Health, Inc. $OPCHMay 15, 2026 | marketbeat.comOPCH SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws ViolationsMay 14, 2026 | globenewswire.comOption Care Health, Inc. (OPCH) Presents at Bank of America Global Healthcare Conference 2026 - SlideshowMay 14, 2026 | seekingalpha.comIndependent Director of Option Care Health Picks Up 49% More StockMay 14, 2026 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesThe Real SpaceX Play: 5 Chip Stocks Powering the IPO Before It LaunchesBy Bridget Bennett | May 4, 2026The Crude Reality: Pullback Creates High-Conviction Opportunity in ChevronBy Jeffrey Neal Johnson | April 29, 20263 Overlooked Nuclear Fuel Supply Chain WinnersBy Nathan Reiff | April 26, 2026Did Qualcomm Just Put Apple in Check?By Jeffrey Neal Johnson | April 28, 2026Qualcomm’s 50% Surge: Bubble Territory or Breakout Moment?By Sam Quirke | May 4, 2026CHE, AMED, OPCH, and AHCO Company DescriptionsAdaptHealth NASDAQ:AHCO$10.45 -0.08 (-0.76%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$10.45 0.00 (0.00%) As of 05/22/2026 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It also offers wheelchairs, hospital beds, oxygen concentrators, CPAP masks and related supplies, wound care supplies, diabetes management supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania.Amedisys NASDAQ:AMEDAmedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.Chemed NYSE:CHE$439.70 -1.85 (-0.42%) Closing price 05/22/2026 03:59 PM EasternExtended Trading$439.27 -0.43 (-0.10%) As of 05/22/2026 05:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.Option Care Health NASDAQ:OPCH$20.93 -0.59 (-2.74%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$20.75 -0.18 (-0.86%) As of 05/22/2026 06:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/18 - 05/22 Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus? Workday Validates AI Flywheel: Stock Price Recovery Begins SpaceX IPO: Opportunity? Or the Ultimate Hype Trade? Overextended, e.l.f. Beauty Is Primed to Rebound in Back Half Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook NVIDIA Price Pullback? Don’t Count on It, Business Is Accelerating Palantir and Dell Build an AI OS for the Paranoid Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
